
Kristina M. Ødegaard
@kristinamalene
🩺 MD 🎓 PhD ❤️🔥Heart Failure epidemiology and pharmacoepidemiology with a passion for RWE | Medical Advisor Novartis. 🦅 My personal veiws
ID: 452090315
01-01-2012 11:59:10
11 Tweet
58 Followers
139 Following

Thanks for being role models to “our sort”, addressing important topics such as sex differences in cardiovascular disease, underrepresentation of women in clinical trials, the value of story telling and interdisciplinary partnerships! Trisha Greenhalgh Carolyn Lam Universitetet i Oslo


Hot off the press: We found poor compliance to pharmacotherapy in patients with heart failure in Norway from 2014–2020 🇳🇴 Sigrun Halvorsen European Society of Cardiology Journals onlinelibrary.wiley.com/doi/10.1002/eh…

Assessing low-risk pts w/chest pain in emergency primary care👩⚕️, using the 0/1h hs-cTnT algorithm, appears cost-effective compared to🏥 💶Costs -1794 EUR/pt ⏲️LOS -18.9h 🏡Not hospitalised 87 % Sigrun Halvorsen Dan Atar Torbjørn Wisløff John Munkhaugen Health Services Research at BMC bmchealthservres.biomedcentral.com/articles/10.11…

Great potential for improvement of lipid management in Norway! Nationwide study covering all dispensed LLTs in pts <80 yrs: -39% with discontinuation or gaps >180days - suboptimal statin doses and few on ezetimibe Oslo Economics Sigrun Halvorsen Kristina M. Ødegaard academic.oup.com/ehjopen/advanc…


May the 4th was with me! Thankful for everyone involved and participating at my phd-defense. It was such a great day Sigrun Halvorsen UiO - Det medisinske fakultet Charlotte B. Ingul Kåre Birkeland @larskøber Henrik Schirmer


Academic tourism with beatiful people! 🥰🫀🌟 Kristina M. Ødegaard @TeaTereng Arnhild Bakken #ESCCongress2023
